1 |
[otl-200] |
- |
- |
- |
- |
019 1件: 19 💬 |
2 |
Abatacept (aba) + methotrexate (mtx), double-blind (db) |
Abatacept |
3件: D00142 D00142, D02115 D02115, D03203 D03203 💬 |
CD80 4件: CD80, CD86, DHFR, DHFR2 💬 |
Allograft rejection 17件: Allograft rejection, Antifolate resistance, Autoimmune thyroid disease, Biosynthesis of cofactors, Cell adhesion molecules, Folate biosynthesis, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Metabolic pathways, One carbon pool by folate, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
046 1件: 46 💬 |
3 |
Abatacept + methotrexate |
Abatacept |
3件: D00142 D00142, D02115 D02115, D03203 D03203 💬 |
CD80 4件: CD80, CD86, DHFR, DHFR2 💬 |
Allograft rejection 17件: Allograft rejection, Antifolate resistance, Autoimmune thyroid disease, Biosynthesis of cofactors, Cell adhesion molecules, Folate biosynthesis, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Metabolic pathways, One carbon pool by folate, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
046 1件: 46 💬 |
4 |
Adalimumab 40 mg sc every other week |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
271 1件: 271 💬 |
5 |
Adalimumab 40 mg subcutaneous (sc) every other week (eow) |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 1件: 46 💬 |
6 |
Adalimumab with methotrexate |
Adalimumab |
3件: D00142 D00142, D02115 D02115, D02597 D02597 💬 |
DHFR 3件: DHFR, DHFR2, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 69件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 1件: 46 💬 |
7 |
Any other approved antiepileptic drug |
- |
- |
- |
- |
144 1件: 144 💬 |
8 |
Apply veregen ® 10 % on a randomized area and the moisturizing cream of the other side |
- |
- |
- |
- |
160 1件: 160 💬 |
9 |
Apremilast |
Apremilast |
1件: D08860 D08860 💬 |
PDE4A 4件: PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways 5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
046 6件: 46, 50, 56, 97, 162, 271 💬 |
10 |
Apremilast (cc-10004) |
Apremilast |
1件: D08860 D08860 💬 |
PDE4A 4件: PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways 5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
056 1件: 56 💬 |
11 |
Apremilast 20 mg |
Apremilast |
1件: D08860 D08860 💬 |
PDE4A 4件: PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways 5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
046 1件: 46 💬 |
12 |
Apremilast 30 mg |
Apremilast |
1件: D08860 D08860 💬 |
PDE4A 4件: PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways 5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
046 1件: 46 💬 |
13 |
Apremilast 30mg |
Apremilast |
1件: D08860 D08860 💬 |
PDE4A 4件: PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways 5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
050 1件: 50 💬 |
14 |
Apremilast tablet 20 mg |
Apremilast |
1件: D08860 D08860 💬 |
PDE4A 4件: PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways 5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
271 1件: 271 💬 |
15 |
Apremilast tablet 30 mg bid |
Apremilast |
1件: D08860 D08860 💬 |
PDE4A 4件: PDE4A, PDE4B, PDE4C, PDE4D 💬 |
Metabolic pathways 5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway |
271 1件: 271 💬 |
16 |
Azathioprine or methotrexate |
Azathioprine |
4件: D00142 D00142, D00238 D00238, D02115 D02115, D03033 D03033 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
096 1件: 96 💬 |
17 |
Behavioral: other academic sham tutoring |
- |
- |
- |
- |
034 1件: 34 💬 |
18 |
Bmn 110 - every other week |
- |
- |
- |
- |
019 1件: 19 💬 |
19 |
Bmn 110 every other week |
- |
- |
- |
- |
019 1件: 19 💬 |
20 |
Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) |
Digoxin |
13件: D00298 D00298, D00330 D00330, D00455 D00455, D00529 D00529, D00550 D00550, D00696 D00696, D01207 D01207, D01475 D01475, D02290 D02290, D05028 D05028, D05259 D05259, D05261 D05261, D08229 D08229 💬 |
ATP1A1 25件: ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP4A, ATP4B, CYSLTR1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, PTGS1, PTGS2 💬 |
Adrenergic signaling in cardiomyocytes 49件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Arachidonic acid metabolism, Bile secretion, C-type lectin receptor signaling pathway, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chemical carcinogenesis, Collecting duct acid secretion, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Insulin secretion, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pancreatic secretion, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Thyroid hormone signaling pathway, Thyroid hormone synthesis, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 1件: 46 💬 |
21 |
Bms-582949 and methotrexate |
BMS-582949 |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
22 |
Bromocriptine and other dopamine agonists |
Bromocriptine |
4件: D00633 D00633, D00780 D00780, D03165 D03165, D07870 D07870 💬 |
DRD1 6件: DRD1, DRD2, DRD3, DRD4, DRD5, PRL 💬 |
Alcoholism 15件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
23 |
Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf |
Busulfan |
8件: D00107 D00107, D00142 D00142, D00248 D00248, D01907 D01907, D02115 D02115, D03235 D03235, D07966 D07966, D08556 D08556 💬 |
CSF3R 9件: CSF3R, DHFR, DHFR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, RRM1 💬 |
Alzheimer disease 46件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Drug metabolism - other enzymes, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Glutathione metabolism, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Pyrimidine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 1件: 60 💬 |
24 |
Certolizumab pegol + methotrexate (mtx) |
Certolizumab pegol |
3件: D00142 D00142, D02115 D02115, D03441 D03441 💬 |
DHFR 3件: DHFR, DHFR2, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 69件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 1件: 46 💬 |
25 |
Cipro (ciprofloxacin, bayq3939) |
Ciprofloxacin |
2件: D00186 D00186, D02216 D02216 💬 |
- |
- |
299 1件: 299 💬 |
26 |
Ciprofloxacin |
Ciprofloxacin |
2件: D00186 D00186, D02216 D02216 💬 |
- |
- |
002 5件: 2 , 60, 96, 97, 299 💬 |
27 |
Ciprofloxacin (bayq3939) dry powder for inhalation |
Ciprofloxacin |
2件: D00186 D00186, D02216 D02216 💬 |
- |
- |
299 1件: 299 💬 |
28 |
Ciprofloxacin (cipro inhale, bayq3939) |
Ciprofloxacin |
2件: D00186 D00186, D02216 D02216 💬 |
- |
- |
299 1件: 299 💬 |
29 |
Ciprofloxacin (cipro, bayq3939) |
Ciprofloxacin |
2件: D00186 D00186, D02216 D02216 💬 |
- |
- |
299 1件: 299 💬 |
30 |
Ciprofloxacin (ciproxin) |
Ciprofloxacin |
2件: D00186 D00186, D02216 D02216 💬 |
- |
- |
299 1件: 299 💬 |
31 |
Ciprofloxacin dispersion for inhalation |
Ciprofloxacin |
2件: D00186 D00186, D02216 D02216 💬 |
- |
- |
299 1件: 299 💬 |
32 |
Ciprofloxacin dpi |
Ciprofloxacin |
2件: D00186 D00186, D02216 D02216 💬 |
- |
- |
299 1件: 299 💬 |
33 |
Ciprofloxacin dpi (bayq3939) |
Ciprofloxacin |
2件: D00186 D00186, D02216 D02216 💬 |
- |
- |
299 1件: 299 💬 |
34 |
Ciprofloxacin for inhalation |
Ciprofloxacin |
2件: D00186 D00186, D02216 D02216 💬 |
- |
- |
299 1件: 299 💬 |
35 |
Ciprofloxacin hydrochloride |
Ciprofloxacin |
2件: D00186 D00186, D02216 D02216 💬 |
- |
- |
096 2件: 96, 299 💬 |
36 |
Ciprofloxacin hydrochloride monohydrate |
Ciprofloxacin |
2件: D00186 D00186, D02216 D02216 💬 |
- |
- |
299 1件: 299 💬 |
37 |
Ciprofloxacin inhale |
Ciprofloxacin |
2件: D00186 D00186, D02216 D02216 💬 |
- |
- |
299 1件: 299 💬 |
38 |
Clartihromycin, amoxicillin, and omeprazole |
Amoxicillin |
7件: D00229 D00229, D00455 D00455, D01207 D01207, D02925 D02925, D05259 D05259, D05261 D05261, D07452 D07452 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 1件: 6 💬 |
39 |
Clobetasol propionate + methotrexate |
Clobetasol |
4件: D00142 D00142, D01272 D01272, D02115 D02115, D07715 D07715 💬 |
DHFR 3件: DHFR, DHFR2, NR3C1 💬 |
Antifolate resistance 6件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate |
162 1件: 162 💬 |
40 |
Combination product: methotrexate |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
41 |
Cp-690,550 + methotrexate |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
42 |
Cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids |
Azathioprine |
6件: D00142 D00142, D00238 D00238, D00287 D00287, D02115 D02115, D03033 D03033, D07760 D07760 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
044 1件: 44 💬 |
43 |
Cyclosporin, methotrexate (gvhd prophylaxis) |
Cyclosporine |
3件: D00142 D00142, D00184 D00184, D02115 D02115 💬 |
DHFR 7件: DHFR, DHFR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 37件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
326 1件: 326 💬 |
44 |
Diagnostic test: other exploratory blood biomarkers |
- |
- |
- |
- |
298 1件: 298 💬 |
45 |
Diclofenac + omeprazole |
Diclofenac |
7件: D00455 D00455, D00903 D00903, D00904 D00904, D01207 D01207, D05259 D05259, D05261 D05261, D07816 D07816 💬 |
ATP4A 4件: ATP4A, ATP4B, PTGS1, PTGS2 💬 |
Alzheimer disease 26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 1件: 46 💬 |
46 |
Dimebon + omeprazole |
Latrepirdine |
5件: D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261, D09917 D09917 💬 |
ACHE 8件: ACHE, ATP4A, ATP4B, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 26件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Dopaminergic synapse, Gastric acid secretion, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotine addiction, Oxidative phosphorylation, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
008 1件: 8 💬 |
47 |
Dmards (methotrexate |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
48 |
Early immunosuppressants (azathioprine, methotrexate) |
Azathioprine |
4件: D00142 D00142, D00238 D00238, D02115 D02115, D03033 D03033 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
096 1件: 96 💬 |
49 |
Enalapril and other angiotensin converting enzyme inhibitors |
Angiotensin II |
4件: D00150 D00150, D00621 D00621, D02014 D02014, D07892 D07892 💬 |
ACE 3件: ACE, AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications 18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
019 1件: 19 💬 |
50 |
Etanercept + methotrexate |
Etanercept |
3件: D00142 D00142, D00742 D00742, D02115 D02115 💬 |
DHFR 4件: DHFR, DHFR2, LTA, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 69件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 1件: 46 💬 |
51 |
Etanercept , methotrexate |
Etanercept |
3件: D00142 D00142, D00742 D00742, D02115 D02115 💬 |
DHFR 4件: DHFR, DHFR2, LTA, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 69件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 1件: 46 💬 |
52 |
Etanercept, methotrexate and depomedrone |
Etanercept |
3件: D00142 D00142, D00742 D00742, D02115 D02115 💬 |
DHFR 4件: DHFR, DHFR2, LTA, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 69件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 1件: 46 💬 |
53 |
Etanercept, methotrexate, prednisolone |
Etanercept |
11件: D00142 D00142, D00472 D00472, D00742 D00742, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02115 D02115, D02156 D02156, D03301 D03301 💬 |
DHFR 5件: DHFR, DHFR2, LTA, NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 70件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
056 1件: 56 💬 |
54 |
Etanercept, other biologics, disease-modifying antirheumatic drugs (dmards), etc |
Etanercept |
1件: D00742 D00742 💬 |
LTA 2件: LTA, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 1件: 46 💬 |
55 |
Ethylmethylcarbamic acid 3-[(1s)-1-(dimethylamino)ethyl]phenyl ester (**see other 2 names below) |
- |
- |
- |
- |
006 1件: 6 💬 |
56 |
Ezetimibe + other lipid-lowering medication(s) |
Ezetimibe |
1件: D01966 D01966 💬 |
NPC1L1 1件: NPC1L1 💬 |
Fat digestion and absorption 1件: Fat digestion and absorption |
260 1件: 260 💬 |
57 |
Fixed dose combination ciprofloxacin/celecoxib |
Celecoxib |
3件: D00186 D00186, D00567 D00567, D02216 D02216 💬 |
PTGS2 1件: PTGS2 💬 |
Alzheimer disease 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
002 1件: 2 💬 |
58 |
Fluocinolone acetonide |
Fluocinolone |
1件: D01825 D01825 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
090 1件: 90 💬 |
59 |
Genetic: infusion of autologous cryopreserved efs-ada lv cd34+ cells (otl-101) |
- |
- |
- |
- |
065 1件: 65 💬 |
60 |
Genetic: infusion of autologous efs-ada lv cd34+ (otl-101) |
- |
- |
- |
- |
065 1件: 65 💬 |
61 |
Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate) |
Azathioprine |
8件: D00142 D00142, D00238 D00238, D00752 D00752, D02115 D02115, D03033 D03033, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
DHFR 4件: DHFR, DHFR2, IMPDH1, IMPDH2 💬 |
Antifolate resistance 7件: Antifolate resistance, Biosynthesis of cofactors, Drug metabolism - other enzymes, Folate biosynthesis, Metabolic pathways, One carbon pool by folate, Purine metabolism |
049 1件: 49 💬 |
62 |
Infliximab + methotrexate (mtx) |
Infliximab |
3件: D00142 D00142, D02115 D02115, D02598 D02598 💬 |
DHFR 3件: DHFR, DHFR2, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 69件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 1件: 46 💬 |
63 |
Infliximab, methylprednisolone, methotrexate |
Infliximab |
9件: D00142 D00142, D00407 D00407, D00751 D00751, D00979 D00979, D02115 D02115, D02598 D02598, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
DHFR 4件: DHFR, DHFR2, NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 70件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 1件: 46 💬 |
64 |
Intrathecal methotrexate |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
013 1件: 13 💬 |
65 |
L01x - other antineoplastic agents |
- |
- |
- |
- |
085 1件: 85 💬 |
66 |
Losartan and other angiotensin receptor blockers |
Angiotensin II |
4件: D00150 D00150, D00357 D00357, D02014 D02014, D08146 D08146 💬 |
AGTR1 2件: AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
019 1件: 19 💬 |
67 |
M2951 (other name: evobrutinib) |
Evobrutinib |
- |
- |
- |
049 1件: 49 💬 |
68 |
Methotrexate |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
011 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬 |
69 |
Methotrexate 'lederle' 2,5mg tablets |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
70 |
Methotrexate 'lederle' 2.5mg tablets |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
71 |
Methotrexate 'lederle' tablets |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
72 |
Methotrexate (metoject® prefilled pen) |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
73 |
Methotrexate (mtx) |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
74 |
Methotrexate (stable dose) |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
75 |
Methotrexate (tapering dose) |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
76 |
Methotrexate + biologic administration |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
77 |
Methotrexate + infliximab |
Infliximab |
3件: D00142 D00142, D02115 D02115, D02598 D02598 💬 |
DHFR 3件: DHFR, DHFR2, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 69件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 1件: 46 💬 |
78 |
Methotrexate + methylprednisolone |
Methotrexate |
8件: D00142 D00142, D00407 D00407, D00751 D00751, D00979 D00979, D02115 D02115, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
DHFR 3件: DHFR, DHFR2, NR3C1 💬 |
Antifolate resistance 6件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate |
046 1件: 46 💬 |
79 |
Methotrexate + salazopyrine + hydroxychloroquine administration |
Hydroxychloroquine |
3件: D00142 D00142, D02115 D02115, D08050 D08050 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
80 |
Methotrexate - amneal |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
81 |
Methotrexate - dava |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
82 |
Methotrexate - delay |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
83 |
Methotrexate - etanercept - prednisolone arm |
Etanercept |
11件: D00142 D00142, D00472 D00472, D00742 D00742, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02115 D02115, D02156 D02156, D03301 D03301 💬 |
DHFR 5件: DHFR, DHFR2, LTA, NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 70件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 1件: 46 💬 |
84 |
Methotrexate - immediate |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
85 |
Methotrexate 10 mg |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
86 |
Methotrexate 10 mg tablets |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
87 |
Methotrexate 2.5 mg |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
044 1件: 44 💬 |
88 |
Methotrexate 2.5 mg tablets |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
89 |
Methotrexate 2.5mg tablets |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
90 |
Methotrexate 2.5mg tablets bp |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
91 |
Methotrexate 25 mg |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
044 1件: 44 💬 |
92 |
Methotrexate 50mg/ml solution for injection, pre-filled syringe |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
93 |
Methotrexate ``lederle`` 2.5mg tablets |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
94 |
Methotrexate and folic acid |
Folic acid |
3件: D00070 D00070, D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
049 1件: 49 💬 |
95 |
Methotrexate as methotrexate disodium |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
96 |
Methotrexate bellon |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
097 1件: 97 💬 |
97 |
Methotrexate bellon 25mg/ml |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
097 1件: 97 💬 |
98 |
Methotrexate capsules |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
99 |
Methotrexate disodium |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 3件: 46, 96, 97 💬 |
100 |
Methotrexate ebewe |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
101 |
Methotrexate hospira 2,5 mg tablety |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
102 |
Methotrexate hospira 2.5 mg tablety |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
103 |
Methotrexate injection |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
096 2件: 96, 97 💬 |
104 |
Methotrexate lachema 5inj. sol |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
050 1件: 50 💬 |
105 |
Methotrexate lederle 2.5 mg tablets |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
106 |
Methotrexate pfizer 2,5 mg tabletter |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
107 |
Methotrexate placebo |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
108 |
Methotrexate plus enbrel or enbrel alone |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
109 |
Methotrexate plus erb-041 for 12 weeks |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
110 |
Methotrexate plus sulfasalazine |
Methotrexate |
3件: D00142 D00142, D00448 D00448, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
111 |
Methotrexate pre-filled pen |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
112 |
Methotrexate prefilled pen |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
113 |
Methotrexate prefilled syringe |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
114 |
Methotrexate sodium |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 2件: 46, 256 💬 |
115 |
Methotrexate sodium 2.5mg tablets |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
116 |
Methotrexate sodium tablets 2.5 mg |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
117 |
Methotrexate sodium tablets 2.5mg |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
118 |
Methotrexate tablets |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
040 1件: 40 💬 |
119 |
Methotrexate tablets 2.5 mg |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
120 |
Methotrexate treatment |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
041 2件: 41, 46 💬 |
121 |
Methotrexate wyeth 2,5mg |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
050 1件: 50 💬 |
122 |
Methotrexate wyeth 2,5mg tbl. |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
050 1件: 50 💬 |
123 |
Methotrexate ® 2.5mg tablets |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
124 |
Methotrexate(mtx) |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
125 |
Methotrexate(mtx) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
126 |
Methotrexate(mtx) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol. |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
127 |
Methotrexate(necessary) |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
128 |
Methotrexate*100cpr 2,5mg |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
129 |
Methotrexate*10mg/1,33ml 4s |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
130 |
Methotrexate*15mg/2ml 4sir |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
131 |
Methotrexate*2,5mg 25cpr |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
132 |
Methotrexate*20mg/2,66ml 4s |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
133 |
Methotrexate*25cpr 2,5mg |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
134 |
Methotrexate*7,5mg/ml 4sir. |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
135 |
Methotrexate, leucovorin and bms-986142 |
BMS-986142 |
5件: D00142 D00142, D01211 D01211, D02115 D02115, D07986 D07986, D07987 D07987 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
136 |
Methotrexate,adalimumab |
Adalimumab |
3件: D00142 D00142, D02115 D02115, D02597 D02597 💬 |
DHFR 3件: DHFR, DHFR2, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 69件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 1件: 46 💬 |
137 |
Methotrexate-lachema |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
138 |
Methotrexate-sulfasalazine-hydroxychloroquine |
Hydroxychloroquine |
4件: D00142 D00142, D00448 D00448, D02115 D02115, D08050 D08050 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
139 |
Methotrexate® 2.5 mg tablets |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
140 |
Methylprednisolone (or other glucocorticoid) |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
043 1件: 43 💬 |
141 |
Mp-435(dose1) + methotrexate |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
142 |
Msdmds other than betaseron (interferon beta-1b, bay86-5046) |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
143 |
Mycophenolate mofetil,methotrexate |
Methotrexate |
6件: D00142 D00142, D00752 D00752, D02115 D02115, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
DHFR 4件: DHFR, DHFR2, IMPDH1, IMPDH2 💬 |
Antifolate resistance 7件: Antifolate resistance, Biosynthesis of cofactors, Drug metabolism - other enzymes, Folate biosynthesis, Metabolic pathways, One carbon pool by folate, Purine metabolism |
042 3件: 42, 43, 45 💬 |
144 |
Naproxen 500 mg tablets (pn 200 minus omeprazole) |
Naproxen |
5件: D00118 D00118, D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A 4件: ATP4A, ATP4B, PTGS1, PTGS2 💬 |
Alzheimer disease 26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 2件: 46, 271 💬 |
145 |
Omeprazole |
Omeprazole |
4件: D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 16件: 6 , 8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬 |
146 |
Omeprazole (uk licensed generic product) |
Omeprazole |
4件: D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
085 1件: 85 💬 |
147 |
Omeprazole 20 mg |
Omeprazole |
4件: D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
096 2件: 96, 97 💬 |
148 |
Omeprazole 20mg |
Omeprazole |
4件: D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
051 1件: 51 💬 |
149 |
Omeprazole 20mg bid |
Omeprazole |
4件: D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
098 1件: 98 💬 |
150 |
Omeprazole 40 mg |
Omeprazole |
4件: D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
096 1件: 96 💬 |
151 |
Omeprazole 40mg capsule |
Omeprazole |
4件: D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
299 1件: 299 💬 |
152 |
Omeprazole magnesium |
Magnesium |
4件: D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
225 1件: 225 💬 |
153 |
Omeprazole rectally 1mg/kg |
Omeprazole |
4件: D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
294 1件: 294 💬 |
154 |
Oral ciprofloxacin |
Ciprofloxacin |
2件: D00186 D00186, D02216 D02216 💬 |
- |
- |
299 1件: 299 💬 |
155 |
Oral ciprofloxacin plus inhaled colistin |
Ciprofloxacin |
4件: D00186 D00186, D02138 D02138, D02216 D02216, D07746 D07746 💬 |
- |
- |
299 1件: 299 💬 |
156 |
Oral methotrexate |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
157 |
Ot |
- |
- |
- |
- |
193 1件: 193 💬 |
158 |
Otelixizumab |
Otelixizumab |
1件: D08959 D08959 💬 |
CD3D 3件: CD3D, CD3E, CD3G 💬 |
Chagas disease 11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
046 1件: 46 💬 |
159 |
Otezla |
- |
- |
- |
- |
056 2件: 56, 162 💬 |
160 |
Other analgesics and antipyretics |
- |
- |
- |
- |
013 1件: 13 💬 |
161 |
Other antiepileptics |
- |
- |
- |
- |
140 1件: 140 💬 |
162 |
Other biologic therapies |
- |
- |
- |
- |
096 1件: 96 💬 |
163 |
Other biological agent |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
164 |
Other biologics |
- |
- |
- |
- |
046 1件: 46 💬 |
165 |
Other cox-2 inhibitor |
- |
- |
- |
- |
271 1件: 271 💬 |
166 |
Other cox-2 inhibitors |
- |
- |
- |
- |
271 1件: 271 💬 |
167 |
Other crystalloid |
- |
- |
- |
- |
296 1件: 296 💬 |
168 |
Other disease-modifying therapy |
- |
- |
- |
- |
013 1件: 13 💬 |
169 |
Other dmards |
- |
- |
- |
- |
046 1件: 46 💬 |
170 |
Other h1 antagonist |
- |
- |
- |
- |
013 1件: 13 💬 |
171 |
Other hematological agents |
- |
- |
- |
- |
065 1件: 65 💬 |
172 |
Other nervous system drugs |
- |
- |
- |
- |
006 2件: 6 , 13 💬 |
173 |
Other non steroidal anti-inflammatory drugs (nsaids) except etodolac |
Etodolac |
1件: D00315 D00315 💬 |
PTGS2 1件: PTGS2 💬 |
Alzheimer disease 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 1件: 46 💬 |
174 |
Other non-selective nsaids |
- |
- |
- |
- |
271 1件: 271 💬 |
175 |
Other non-sponsor pancreatic enzyme replacement therapy |
- |
- |
- |
- |
299 1件: 299 💬 |
176 |
Other parkinson's disease treatments |
- |
- |
- |
- |
006 1件: 6 💬 |
177 |
Other respiratory system products |
- |
- |
- |
- |
299 1件: 299 💬 |
178 |
Other sources |
- |
- |
- |
- |
228 1件: 228 💬 |
179 |
Other vasodilator |
- |
- |
- |
- |
051 1件: 51 💬 |
180 |
Other: |
- |
- |
- |
- |
002 2件: 2 , 65 💬 |
181 |
Other: 0 mg |
- |
- |
- |
- |
097 1件: 97 💬 |
182 |
Other: 0.02% fm, sh, tbcl |
- |
- |
- |
- |
053 1件: 53 💬 |
183 |
Other: 0.9% sodium chloride |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
065 1件: 65 💬 |
184 |
Other: 0.9ml sodium chloride |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
271 1件: 271 💬 |
185 |
Other: 1 food elimination diet |
- |
- |
- |
- |
098 1件: 98 💬 |
186 |
Other: 1 food elimination diet therapy |
- |
- |
- |
- |
098 1件: 98 💬 |
187 |
Other: 100% pomegranate juice |
Pomegranate |
- |
- |
- |
096 2件: 96, 97 💬 |
188 |
Other: 13c6 leucine |
Leucine |
1件: D00030 D00030 💬 |
- |
- |
005 3件: 5 , 7 , 127 💬 |
189 |
Other: 18f-fdg |
Fludeoxyglucose (18F) |
- |
- |
- |
046 2件: 46, 84 💬 |
190 |
Other: 18f-fdg pet/ct |
Fludeoxyglucose (18F) |
- |
- |
- |
041 1件: 41 💬 |
191 |
Other: 18f-fluorodeoxyglucose (18f-fdg) pet/ct |
Fludeoxyglucose (18F) |
- |
- |
- |
084 1件: 84 💬 |
192 |
Other: 18f-ge-180 |
Flutriciclamide F-18 |
- |
- |
- |
046 1件: 46 💬 |
193 |
Other: 2h standardized aerobic exercise |
- |
- |
- |
- |
078 1件: 78 💬 |
194 |
Other: 31-phosphorus rmn spectroscopy |
Phosphorus |
- |
- |
- |
008 1件: 8 💬 |
195 |
Other: 4 food elimination diet |
- |
- |
- |
- |
098 1件: 98 💬 |
196 |
Other: 4 food elimination diet (post 1fed failure) |
- |
- |
- |
- |
098 1件: 98 💬 |
197 |
Other: 5-asa withdrawal |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 1件: 96 💬 |
198 |
Other: 6 food elimination diet (after 1fed failure) |
- |
- |
- |
- |
098 1件: 98 💬 |
199 |
Other: 6 food elimination diet therapy |
- |
- |
- |
- |
098 1件: 98 💬 |
200 |
Other: 60% oxygen |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
085 1件: 85 💬 |
201 |
Other: [11c]-methionine pet/mri |
Methionine |
2件: D00019 D00019, D04983 D04983 💬 |
- |
- |
075 1件: 75 💬 |
202 |
Other: [11c]donepezil pet |
Donepezil |
2件: D00670 D00670, D07869 D07869 💬 |
ACHE 1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
006 1件: 6 💬 |
203 |
Other: a-step |
- |
- |
- |
- |
299 1件: 299 💬 |
204 |
Other: a-step (new protocol) |
- |
- |
- |
- |
299 1件: 299 💬 |
205 |
Other: abdominal compression |
- |
- |
- |
- |
017 1件: 17 💬 |
206 |
Other: absorptive clearance scan |
- |
- |
- |
- |
299 1件: 299 💬 |
207 |
Other: acute response to high-impact exercise |
- |
- |
- |
- |
096 1件: 96 💬 |
208 |
Other: ad libitum water intake |
Water |
1件: D00001 D00001 💬 |
- |
- |
067 1件: 67 💬 |
209 |
Other: adalimumab |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 1件: 46 💬 |
210 |
Other: adalimumab treatment |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
151 1件: 151 💬 |
211 |
Other: additional therapies |
- |
- |
- |
- |
097 1件: 97 💬 |
212 |
Other: air - oxygen |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
299 1件: 299 💬 |
213 |
Other: amyotrophic lateral sclerosis functional rating scale-revised |
- |
- |
- |
- |
002 1件: 2 💬 |
214 |
Other: antigen (wheat base soy sauce) spray |
Wheat |
1件: D06902 D06902 💬 |
- |
- |
098 1件: 98 💬 |
215 |
Other: anxiety |
- |
- |
- |
- |
013 1件: 13 💬 |
216 |
Other: assessment of medication compliance |
- |
- |
- |
- |
098 1件: 98 💬 |
217 |
Other: autogenic drainage |
- |
- |
- |
- |
299 1件: 299 💬 |
218 |
Other: autologous platelet rich plasma |
- |
- |
- |
- |
035 1件: 35 💬 |
219 |
Other: autologous serum and rebamipide 2% |
Rebamipide |
1件: D01121 D01121 💬 |
- |
- |
053 1件: 53 💬 |
220 |
Other: avise pg - diagnostic test |
- |
- |
- |
- |
046 1件: 46 💬 |
221 |
Other: balance |
Isoxaflutole |
- |
- |
- |
006 3件: 6 , 13, 299 💬 |
222 |
Other: balance exercise |
Isoxaflutole |
- |
- |
- |
006 1件: 6 💬 |
223 |
Other: balance exercises |
Isoxaflutole |
- |
- |
- |
013 1件: 13 💬 |
224 |
Other: balance trainer balance exercises |
Isoxaflutole |
- |
- |
- |
013 1件: 13 💬 |
225 |
Other: balance training |
Isoxaflutole |
- |
- |
- |
006 2件: 6 , 13 💬 |
226 |
Other: baseline serum vitamin d level at or above 50 nmol/l |
Vitamin D |
- |
- |
- |
046 1件: 46 💬 |
227 |
Other: baseline serum vitamin d level below 50 nmol/l |
Vitamin D |
- |
- |
- |
046 1件: 46 💬 |
228 |
Other: beetroot juice extract |
- |
- |
- |
- |
113 1件: 113 💬 |
229 |
Other: berg balance scale |
Isoxaflutole |
- |
- |
- |
006 2件: 6 , 13 💬 |
230 |
Other: best medical treatment |
- |
- |
- |
- |
006 1件: 6 💬 |
231 |
Other: best practice |
- |
- |
- |
- |
060 1件: 60 💬 |
232 |
Other: biological samples |
- |
- |
- |
- |
206 1件: 206 💬 |
233 |
Other: biopsy |
- |
- |
- |
- |
051 1件: 51 💬 |
234 |
Other: blood collection for measurement of eculizumab peak concentrations |
Eculizumab |
1件: D03940 D03940 💬 |
C5 1件: C5 💬 |
Complement and coagulation cascades 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
062 1件: 62 💬 |
235 |
Other: blood drawing only group c |
- |
- |
- |
- |
049 1件: 49 💬 |
236 |
Other: blood glucose results |
Dextrose, unspecified form |
- |
- |
- |
299 1件: 299 💬 |
237 |
Other: blood sample |
- |
- |
- |
- |
299 1件: 299 💬 |
238 |
Other: blood sample and cotton skin swabs |
Cotton |
- |
- |
- |
162 1件: 162 💬 |
239 |
Other: blood samples |
- |
- |
- |
- |
093 1件: 93 💬 |
240 |
Other: blood sampling for laboratory developed test (ldt) analysis |
- |
- |
- |
- |
065 1件: 65 💬 |
241 |
Other: blood test |
- |
- |
- |
- |
096 1件: 96 💬 |
242 |
Other: blood-flow restricted training |
- |
- |
- |
- |
015 1件: 15 💬 |
243 |
Other: bmi greater than or equal to 30kg/m2 scheduled for psg. undergo blood draw (arterial blood gas and metabolic panel) and data collection from psg study. |
- |
- |
- |
- |
230 1件: 230 💬 |
244 |
Other: bmi greater than or equal to 30kg/m2 scheduled for psg. undergo blood draw (venous blood gas and metabolic panel) and data collection from psg study. |
- |
- |
- |
- |
230 1件: 230 💬 |
245 |
Other: bone marrow cell transplantation |
- |
- |
- |
- |
274 1件: 274 💬 |
246 |
Other: brain mri (magnetic resonance imaging) |
- |
- |
- |
- |
017 1件: 17 💬 |
247 |
Other: brief pain inventory questionnaire |
- |
- |
- |
- |
019 1件: 19 💬 |
248 |
Other: bronchoalveolar samples |
- |
- |
- |
- |
051 1件: 51 💬 |
249 |
Other: caffeine |
Caffeine |
2件: D00528 D00528, D01453 D01453 💬 |
ADORA1 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
250 |
Other: calcium stable isotope |
Calcium |
- |
- |
- |
186 1件: 186 💬 |
251 |
Other: carbon monoxide-bubbled mediums |
Activated charcoal |
2件: D03251 D03251, D09706 D09706 💬 |
- |
- |
298 1件: 298 💬 |
252 |
Other: carboxy methyl cellulose |
Methylcellulose |
2件: D00093 D00093, D04996 D04996 💬 |
- |
- |
053 1件: 53 💬 |
253 |
Other: cardiopulmonary evaluation |
- |
- |
- |
- |
013 1件: 13 💬 |
254 |
Other: cawthorne cooksey exercises |
- |
- |
- |
- |
013 1件: 13 💬 |
255 |
Other: cd lfd |
- |
- |
- |
- |
096 1件: 96 💬 |
256 |
Other: cd-treat diet |
- |
- |
- |
- |
096 1件: 96 💬 |
257 |
Other: challenge agent: capsaicin |
Capsaicin |
1件: D00250 D00250 💬 |
TRPV1 1件: TRPV1 💬 |
Inflammatory mediator regulation of TRP channels 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
019 1件: 19 💬 |
258 |
Other: classic, progressive endurance training |
- |
- |
- |
- |
013 1件: 13 💬 |
259 |
Other: coa-z |
- |
- |
- |
- |
120 1件: 120 💬 |
260 |
Other: coaching sessions |
- |
- |
- |
- |
049 1件: 49 💬 |
261 |
Other: coduse balance training and step square exercises |
Isoxaflutole |
- |
- |
- |
013 1件: 13 💬 |
262 |
Other: coffee |
- |
- |
- |
- |
096 1件: 96 💬 |
263 |
Other: cognitive training |
- |
- |
- |
- |
206 1件: 206 💬 |
264 |
Other: colchicine cessation |
Colchicine |
1件: D00570 D00570 💬 |
TUBB 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease 10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
266 1件: 266 💬 |
265 |
Other: collection of csf, blood, urine, saliva |
- |
- |
- |
- |
006 1件: 6 💬 |
266 |
Other: communicative effectiveness survey |
- |
- |
- |
- |
002 1件: 2 💬 |
267 |
Other: comparator: cpet cycle ergometer (gold standard) |
Gold |
- |
- |
- |
299 1件: 299 💬 |
268 |
Other: computer game based balance and walking rehabilitation for individuals with parkinson's disease |
Isoxaflutole |
- |
- |
- |
006 1件: 6 💬 |
269 |
Other: concomitant medication |
- |
- |
- |
- |
049 1件: 49 💬 |
270 |
Other: continuation of dornase alfa (dnase) |
Dornase alfa |
1件: D03896 D03896 💬 |
- |
- |
299 1件: 299 💬 |
271 |
Other: continuation of hypertonic saline (hs) |
- |
- |
- |
- |
299 1件: 299 💬 |
272 |
Other: continue their usual therapy |
- |
- |
- |
- |
066 1件: 66 💬 |
273 |
Other: control |
- |
- |
- |
- |
006 8件: 6 , 19, 70, 75, 85, 97, 162, 193 💬 |
274 |
Other: control diet |
- |
- |
- |
- |
096 1件: 96 💬 |
275 |
Other: control group |
- |
- |
- |
- |
002 1件: 2 💬 |
276 |
Other: control group(normal saline) |
- |
- |
- |
- |
097 1件: 97 💬 |
277 |
Other: control wound treatment |
- |
- |
- |
- |
036 1件: 36 💬 |
278 |
Other: controlled environment tests (series of tasks of everyday life) |
- |
- |
- |
- |
006 1件: 6 💬 |
279 |
Other: controls primary cervical dystonia (trihexyphenidyl) |
Trihexyphenidyl |
2件: D00787 D00787, D08638 D08638 💬 |
CHRM1 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 1件: 6 💬 |
280 |
Other: conventional balance training |
Isoxaflutole |
- |
- |
- |
013 1件: 13 💬 |
281 |
Other: conventional drugs |
- |
- |
- |
- |
097 1件: 97 💬 |
282 |
Other: conventional pca mode |
- |
- |
- |
- |
070 1件: 70 💬 |
283 |
Other: core stability |
- |
- |
- |
- |
013 1件: 13 💬 |
284 |
Other: corn starch |
Starch, corn |
1件: D05297 D05297 💬 |
- |
- |
049 1件: 49 💬 |
285 |
Other: corticotropin releasing hormone (crh) |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
078 1件: 78 💬 |
286 |
Other: cough monitor |
Methamidophos |
- |
- |
- |
085 1件: 85 💬 |
287 |
Other: crohn's disease treatment-with-eating diet (cd-treat diet) |
- |
- |
- |
- |
096 1件: 96 💬 |
288 |
Other: crohns disease exclusion diet |
- |
- |
- |
- |
096 1件: 96 💬 |
289 |
Other: cultured thymus tissue implantation and parental parathyroid transplantation |
- |
- |
- |
- |
065 1件: 65 💬 |
290 |
Other: cultured thymus tissue implantation with parathyroid transplantation |
- |
- |
- |
- |
065 1件: 65 💬 |
291 |
Other: current treatment |
- |
- |
- |
- |
046 1件: 46 💬 |
292 |
Other: cyclosporin a |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 1件: 60 💬 |
293 |
Other: cysteamine bitartrate |
Cysteamine |
2件: D03634 D03634, D03635 D03635 💬 |
- |
- |
019 1件: 19 💬 |
294 |
Other: d-xylose |
Xylose |
1件: D06346 D06346 💬 |
- |
- |
098 1件: 98 💬 |
295 |
Other: d5w |
- |
- |
- |
- |
222 1件: 222 💬 |
296 |
Other: data capture |
Bifenthrin |
- |
- |
- |
006 1件: 6 💬 |
297 |
Other: dead sea solar and water treatment |
Water |
1件: D00001 D00001 💬 |
- |
- |
046 1件: 46 💬 |
298 |
Other: determination of calcium intake by a dietician interview |
Calcium |
- |
- |
- |
013 2件: 13, 46 💬 |
299 |
Other: dextrose water 5% |
Dextrose, unspecified form |
1件: D00001 D00001 💬 |
- |
- |
056 1件: 56 💬 |
300 |
Other: diagnostic laboratory biomarker analysis |
- |
- |
- |
- |
074 1件: 74 💬 |
301 |
Other: diagnostics for glucose tolerance with 3 different methods. |
Dextrose, unspecified form |
- |
- |
- |
299 1件: 299 💬 |
302 |
Other: diary completion |
- |
- |
- |
- |
006 1件: 6 💬 |
303 |
Other: diet |
- |
- |
- |
- |
240 1件: 240 💬 |
304 |
Other: diet treatment |
- |
- |
- |
- |
240 1件: 240 💬 |
305 |
Other: diet-cd |
- |
- |
- |
- |
096 1件: 96 💬 |
306 |
Other: dietary intervention with no-carrageenan diet |
- |
- |
- |
- |
097 1件: 97 💬 |
307 |
Other: discontinuation of dornase alfa (dnase) |
Dornase alfa |
1件: D03896 D03896 💬 |
- |
- |
299 1件: 299 💬 |
308 |
Other: discontinuation of hypertonic saline (hs) |
- |
- |
- |
- |
299 1件: 299 💬 |
309 |
Other: dmt withdrawal |
- |
- |
- |
- |
013 1件: 13 💬 |
310 |
Other: dobutamine |
Dobutamine |
4件: D00632 D00632, D03879 D03879, D03880 D03880, D03881 D03881 💬 |
ADRB1 1件: ADRB1 💬 |
Adrenergic signaling in cardiomyocytes 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
215 1件: 215 💬 |
311 |
Other: donor derived g-csf mobilized pbc |
Filgrastim |
1件: D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
060 1件: 60 💬 |
312 |
Other: donor lymphocyte infusion |
- |
- |
- |
- |
065 1件: 65 💬 |
313 |
Other: dose reduction to 2mg/l |
- |
- |
- |
- |
046 1件: 46 💬 |
314 |
Other: dose reduction to 5mg/l |
- |
- |
- |
- |
046 1件: 46 💬 |
315 |
Other: drug free |
- |
- |
- |
- |
049 1件: 49 💬 |
316 |
Other: dual task performance |
- |
- |
- |
- |
013 1件: 13 💬 |
317 |
Other: dummy tripterygium wilfordii hook f (twhf) |
Tripterygium wilfordii whole |
- |
- |
- |
046 1件: 46 💬 |
318 |
Other: dynamic balance training |
Isoxaflutole |
- |
- |
- |
013 1件: 13 💬 |
319 |
Other: dystrophin levels |
- |
- |
- |
- |
113 1件: 113 💬 |
320 |
Other: dyt 1 dystonia |
- |
- |
- |
- |
006 1件: 6 💬 |
321 |
Other: dyt 1 dystonia (healthy control) |
- |
- |
- |
- |
006 1件: 6 💬 |
322 |
Other: e-monitoring |
- |
- |
- |
- |
097 1件: 97 💬 |
323 |
Other: eating assessment tool 10 |
- |
- |
- |
- |
002 1件: 2 💬 |
324 |
Other: eating assessment tool-10 |
- |
- |
- |
- |
002 1件: 2 💬 |
325 |
Other: echocardiogram |
- |
- |
- |
- |
113 1件: 113 💬 |
326 |
Other: eculizumab |
Eculizumab |
1件: D03940 D03940 💬 |
C5 1件: C5 💬 |
Complement and coagulation cascades 9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
109 1件: 109 💬 |
327 |
Other: eit |
- |
- |
- |
- |
228 1件: 228 💬 |
328 |
Other: electroencephalogram (eeg) awake andextended overnight |
- |
- |
- |
- |
019 1件: 19 💬 |
329 |
Other: elimination diet |
- |
- |
- |
- |
098 1件: 98 💬 |
330 |
Other: empiric use of calcium carbonate and calcitriol |
Calcitriol |
3件: D00129 D00129, D00932 D00932, D10802 D10802 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
235 1件: 235 💬 |
331 |
Other: endurance |
- |
- |
- |
- |
006 1件: 6 💬 |
332 |
Other: enteral nutrition |
- |
- |
- |
- |
096 1件: 96 💬 |
333 |
Other: epiduroscopy |
- |
- |
- |
- |
070 1件: 70 💬 |
334 |
Other: epistaxis charts |
- |
- |
- |
- |
227 1件: 227 💬 |
335 |
Other: eus procedure |
- |
- |
- |
- |
298 1件: 298 💬 |
336 |
Other: evaluation by investigator |
- |
- |
- |
- |
006 1件: 6 💬 |
337 |
Other: evaluation of degree chronic fatigue. |
- |
- |
- |
- |
013 1件: 13 💬 |
338 |
Other: event-related evoked potential using electroencephalography (eeg). |
- |
- |
- |
- |
006 1件: 6 💬 |
339 |
Other: exclusion diet |
- |
- |
- |
- |
096 1件: 96 💬 |
340 |
Other: exclusive enteral nutrition |
- |
- |
- |
- |
096 1件: 96 💬 |
341 |
Other: exclusive enteral nutrition (een) |
- |
- |
- |
- |
096 1件: 96 💬 |
342 |
Other: exercise capacity |
- |
- |
- |
- |
299 1件: 299 💬 |
343 |
Other: exercise echocardiography |
- |
- |
- |
- |
058 1件: 58 💬 |
344 |
Other: exercise followed cold water immersion |
Water |
1件: D00001 D00001 💬 |
- |
- |
046 1件: 46 💬 |
345 |
Other: exercise intervention |
- |
- |
- |
- |
013 2件: 13, 18 💬 |
346 |
Other: faecal bacterial transplantation |
- |
- |
- |
- |
097 1件: 97 💬 |
347 |
Other: fast mimicking diet |
- |
- |
- |
- |
097 1件: 97 💬 |
348 |
Other: fatigue |
- |
- |
- |
- |
013 1件: 13 💬 |
349 |
Other: fear of falling |
- |
- |
- |
- |
013 1件: 13 💬 |
350 |
Other: fingolimod |
Fingolimod |
1件: D10001 D10001 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 1件: 13 💬 |
351 |
Other: fitbit activity monitor |
Methamidophos |
- |
- |
- |
049 1件: 49 💬 |
352 |
Other: flow cytometry |
- |
- |
- |
- |
028 3件: 28, 51, 60 💬 |
353 |
Other: fluid restriction |
- |
- |
- |
- |
072 1件: 72 💬 |
354 |
Other: fluorescein angiography |
Fluorescein |
2件: D01261 D01261, D02024 D02024 💬 |
- |
- |
019 1件: 19 💬 |
355 |
Other: fog |
- |
- |
- |
- |
006 1件: 6 💬 |
356 |
Other: food diary |
- |
- |
- |
- |
065 1件: 65 💬 |
357 |
Other: four square step test |
- |
- |
- |
- |
006 2件: 6 , 13 💬 |
358 |
Other: fractional exhaled no (feno) |
- |
- |
- |
- |
096 1件: 96 💬 |
359 |
Other: fresh frozen plasma |
- |
- |
- |
- |
014 1件: 14 💬 |
360 |
Other: fruit juice |
- |
- |
- |
- |
299 1件: 299 💬 |
361 |
Other: functional involvement of identified epigenetic alterations |
- |
- |
- |
- |
102 1件: 102 💬 |
362 |
Other: functional mobility |
- |
- |
- |
- |
006 2件: 6 , 13 💬 |
363 |
Other: functional oral intake scale |
- |
- |
- |
- |
002 1件: 2 💬 |
364 |
Other: functional reach test |
- |
- |
- |
- |
006 2件: 6 , 13 💬 |
365 |
Other: gadobutrol |
Gadobutrol |
1件: D07420 D07420 💬 |
- |
- |
046 1件: 46 💬 |
366 |
Other: gait and balance group training |
Isoxaflutole |
- |
- |
- |
006 1件: 6 💬 |
367 |
Other: general and neurological examination |
- |
- |
- |
- |
019 1件: 19 💬 |
368 |
Other: general population |
- |
- |
- |
- |
046 2件: 46, 271 💬 |
369 |
Other: generation of induced pluripotent stem cells (ipsc) from fibroblasts obtained by skin biopsy |
- |
- |
- |
- |
102 1件: 102 💬 |
370 |
Other: gh pause |
- |
- |
- |
- |
078 1件: 78 💬 |
371 |
Other: ghrh plus arginine test |
Arginine |
2件: D02982 D02982, D08523 D08523 💬 |
GHRHR 1件: GHRHR 💬 |
Growth hormone synthesis, secretion and action 2件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction |
078 1件: 78 💬 |
372 |
Other: ghrh+arg, ghrh+arg, itt |
Somatorelin |
1件: D08523 D08523 💬 |
GHRHR 1件: GHRHR 💬 |
Growth hormone synthesis, secretion and action 2件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction |
078 1件: 78 💬 |
373 |
Other: glucose |
Dextrose, unspecified form |
- |
- |
- |
254 1件: 254 💬 |
374 |
Other: glucose -potentiated arginine (gpa) stimulation tests |
Arginine |
1件: D02982 D02982 💬 |
- |
- |
299 1件: 299 💬 |
375 |
Other: glucose profile for 2 weeks |
Dextrose, unspecified form |
- |
- |
- |
299 1件: 299 💬 |
376 |
Other: glucose solution at a dose of 1.75 g/kg (up to a maximum of 75 g) for the ogtt and glucose solution at a dose of 0.5 g/kg (up to a maximum of 35 g) was injected in 2.5-3 min for the igtt |
Dextrose, unspecified form |
- |
- |
- |
299 1件: 299 💬 |
377 |
Other: glycerine gel |
Glycerin |
1件: D00028 D00028 💬 |
- |
- |
265 1件: 265 💬 |
378 |
Other: green tea (camellia sinensis) |
Green tea leaf |
1件: D06903 D06903 💬 |
- |
- |
096 1件: 96 💬 |
379 |
Other: group 2 (dmards treated group) |
- |
- |
- |
- |
046 1件: 46 💬 |
380 |
Other: group b sle one blood donation |
- |
- |
- |
- |
049 1件: 49 💬 |
381 |
Other: group balance training |
Isoxaflutole |
- |
- |
- |
013 1件: 13 💬 |
382 |
Other: group exercise: community setting |
- |
- |
- |
- |
070 1件: 70 💬 |
383 |
Other: growth hormone |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 1件: 78 💬 |
384 |
Other: gsk2586184 single dose taken with food |
- |
- |
- |
- |
049 1件: 49 💬 |
385 |
Other: gsk2586184 single dose taken without food |
- |
- |
- |
- |
049 1件: 49 💬 |
386 |
Other: haematopoietic stem cell transplantation (hsct) |
- |
- |
- |
- |
065 1件: 65 💬 |
387 |
Other: hand training |
- |
- |
- |
- |
046 1件: 46 💬 |
388 |
Other: harkány medicinal water |
Water |
1件: D00001 D00001 💬 |
- |
- |
046 1件: 46 💬 |
389 |
Other: healthy controls |
- |
- |
- |
- |
063 1件: 63 💬 |
390 |
Other: healthy volunteers |
- |
- |
- |
- |
046 1件: 46 💬 |
391 |
Other: hemicellulose crystalline |
- |
- |
- |
- |
006 1件: 6 💬 |
392 |
Other: hepatic elastography |
- |
- |
- |
- |
299 1件: 299 💬 |
393 |
Other: high energy / protein diet. |
- |
- |
- |
- |
096 1件: 96 💬 |
394 |
Other: high glycemic index meal |
- |
- |
- |
- |
299 1件: 299 💬 |
395 |
Other: high intensity exercise and balance training |
Isoxaflutole |
- |
- |
- |
006 1件: 6 💬 |
396 |
Other: high performance liquid chromatography |
- |
- |
- |
- |
096 1件: 96 💬 |
397 |
Other: high resolution peripheral quantitative computed tomography (hrpqct) |
- |
- |
- |
- |
172 1件: 172 💬 |
398 |
Other: high water intake |
Water |
1件: D00001 D00001 💬 |
- |
- |
067 1件: 67 💬 |
399 |
Other: high-impact exercise intervention |
- |
- |
- |
- |
096 1件: 96 💬 |
400 |
Other: histamine |
Histamine |
1件: D08040 D08040 💬 |
HRH1 4件: HRH1, HRH2, HRH3, HRH4 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
401 |
Other: histone acetylation profiles of cells of srt patients with crebbp mutations |
- |
- |
- |
- |
102 1件: 102 💬 |
402 |
Other: historical control |
- |
- |
- |
- |
002 1件: 2 💬 |
403 |
Other: hoehn and yahr scale |
- |
- |
- |
- |
006 1件: 6 💬 |
404 |
Other: honey |
Honey |
1件: D06776 D06776 💬 |
- |
- |
098 1件: 98 💬 |
405 |
Other: human milk derived fortifier |
Cow milk |
- |
- |
- |
210 1件: 210 💬 |
406 |
Other: human umbilical cord-derived mscs and cyclosporin a |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 1件: 60 💬 |
407 |
Other: human/bovine milk |
Cow milk |
- |
- |
- |
210 1件: 210 💬 |
408 |
Other: hydrocortisone |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
075 1件: 75 💬 |
409 |
Other: hydrogen peroxide |
Hydrogen |
1件: D00008 D00008 💬 |
- |
- |
013 1件: 13 💬 |
410 |
Other: hydroxychloroquine/chloroquine |
Chloroquine |
4件: D02125 D02125, D02366 D02366, D03469 D03469, D08050 D08050 💬 |
- |
- |
046 1件: 46 💬 |
411 |
Other: hyperbaric oxygen |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
096 1件: 96 💬 |
412 |
Other: hyperbaric oxygen therapy |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
097 2件: 97, 226 💬 |
413 |
Other: hyperpolarized xenon mri |
Xenon |
2件: D01901 D01901, D06339 D06339 💬 |
- |
- |
299 1件: 299 💬 |
414 |
Other: hypoglycemic clamp |
- |
- |
- |
- |
299 1件: 299 💬 |
415 |
Other: ibuprofen and isosorbide dinitrate combination |
Ibuprofen |
6件: D00126 D00126, D00347 D00347, D00516 D00516, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
113 1件: 113 💬 |
416 |
Other: iloprost (ventavis inhaled, bayq6256) |
Iloprost |
1件: D02721 D02721 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 1件: 86 💬 |
417 |
Other: imaging |
- |
- |
- |
- |
013 1件: 13 💬 |
418 |
Other: imitation surgical procedure (isp) |
- |
- |
- |
- |
006 1件: 6 💬 |
419 |
Other: immunologic technique |
- |
- |
- |
- |
049 1件: 49 💬 |
420 |
Other: impact of biotherapy on postoperative morbidity in ulcerative colitis |
- |
- |
- |
- |
097 1件: 97 💬 |
421 |
Other: impact peptide 1.5 |
- |
- |
- |
- |
299 1件: 299 💬 |
422 |
Other: inactive drug |
- |
- |
- |
- |
226 1件: 226 💬 |
423 |
Other: incontinence severity |
- |
- |
- |
- |
013 1件: 13 💬 |
424 |
Other: individualized exercises: clinical setting |
- |
- |
- |
- |
070 1件: 70 💬 |
425 |
Other: induced hypotonic hyponatremia - siad model |
- |
- |
- |
- |
072 1件: 72 💬 |
426 |
Other: infliximab (ifx) infusion |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
427 |
Other: inhalable hypertonic saline 7% |
- |
- |
- |
- |
299 1件: 299 💬 |
428 |
Other: inhalable hypertonic saline 7% + hyaluronan 0.1% |
Hyaluronic acid |
1件: D08043 D08043 💬 |
- |
- |
299 1件: 299 💬 |
429 |
Other: inhaled hyperpolarized xenon-129 |
Xenon |
2件: D01901 D01901, D06339 D06339 💬 |
- |
- |
228 1件: 228 💬 |
430 |
Other: intensify treatment with the existing drug |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
431 |
Other: intensive supportive care |
- |
- |
- |
- |
066 1件: 66 💬 |
432 |
Other: intrathecal saline injection |
- |
- |
- |
- |
013 1件: 13 💬 |
433 |
Other: isa 51 |
- |
- |
- |
- |
050 1件: 50 💬 |
434 |
Other: isa 51 vg |
- |
- |
- |
- |
049 1件: 49 💬 |
435 |
Other: itt, itt, ghrh+arg. |
Somatorelin |
1件: D08523 D08523 💬 |
GHRHR 1件: GHRHR 💬 |
Growth hormone synthesis, secretion and action 2件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction |
078 1件: 78 💬 |
436 |
Other: iv saline infusion |
- |
- |
- |
- |
096 1件: 96 💬 |
437 |
Other: iv steroids combination alone |
- |
- |
- |
- |
041 1件: 41 💬 |
438 |
Other: ivig |
Human immunoglobulin G |
- |
- |
- |
035 1件: 35 💬 |
439 |
Other: joint mobilizations (spine, sacroiliac, hip) |
- |
- |
- |
- |
070 1件: 70 💬 |
440 |
Other: ketogenic diet |
- |
- |
- |
- |
019 1件: 19 💬 |
441 |
Other: lab work |
- |
- |
- |
- |
046 1件: 46 💬 |
442 |
Other: laboratory biomarker analysis |
- |
- |
- |
- |
011 21件: 11, 13, 14, 16, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 232, 283, 284, 285, 298, 331 💬 |
443 |
Other: language intervention |
- |
- |
- |
- |
206 1件: 206 💬 |
444 |
Other: lengthening adalimumab dosing interval |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
445 |
Other: leukapheresis- collection of stem cells |
- |
- |
- |
- |
096 1件: 96 💬 |
446 |
Other: levothyroxine |
Levothyroxine |
2件: D01010 D01010, D08125 D08125 💬 |
THRA 2件: THRA, THRB 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway |
078 1件: 78 💬 |
447 |
Other: liberation therapy |
- |
- |
- |
- |
013 1件: 13 💬 |
448 |
Other: liquid meal test (carbohydrate-rich) |
- |
- |
- |
- |
299 1件: 299 💬 |
449 |
Other: liquid meal test (fat-rich) |
- |
- |
- |
- |
299 1件: 299 💬 |
450 |
Other: liquid meal test (mixed) |
- |
- |
- |
- |
299 1件: 299 💬 |
451 |
Other: liver evaluation |
- |
- |
- |
- |
240 1件: 240 💬 |
452 |
Other: liver questionnaire |
- |
- |
- |
- |
231 1件: 231 💬 |
453 |
Other: losartan |
Losartan |
2件: D00357 D00357, D08146 D08146 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
046 1件: 46 💬 |
454 |
Other: low blood pressure control |
- |
- |
- |
- |
067 1件: 67 💬 |
455 |
Other: low dose (1 mcg) acth stimulation test |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
193 1件: 193 💬 |
456 |
Other: low glycemic index meal |
- |
- |
- |
- |
299 1件: 299 💬 |
457 |
Other: low n-6 pufa diet |
- |
- |
- |
- |
096 1件: 96 💬 |
458 |
Other: low-intensity exercise therapy |
- |
- |
- |
- |
298 1件: 298 💬 |
459 |
Other: lower limb strength |
- |
- |
- |
- |
006 1件: 6 💬 |
460 |
Other: magnetic resonance imaging (mri) |
- |
- |
- |
- |
113 1件: 113 💬 |
461 |
Other: mangafodipir trisodium |
Mangafodipir |
1件: D08262 D08262 💬 |
- |
- |
058 1件: 58 💬 |
462 |
Other: meal challenge |
- |
- |
- |
- |
240 1件: 240 💬 |
463 |
Other: measure of endothelial function |
- |
- |
- |
- |
299 1件: 299 💬 |
464 |
Other: measurement of drug (adalimumab/infliximab) |
Adalimumab |
2件: D02597 D02597, D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
465 |
Other: medical air |
Medical air |
- |
- |
- |
085 1件: 85 💬 |
466 |
Other: medical chart review |
- |
- |
- |
- |
060 1件: 60 💬 |
467 |
Other: medical history questionnaires |
- |
- |
- |
- |
065 1件: 65 💬 |
468 |
Other: medication compliance phone call |
- |
- |
- |
- |
098 1件: 98 💬 |
469 |
Other: mesalazine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
470 |
Other: metabolic exercise testing using stationary bicycle |
- |
- |
- |
- |
113 1件: 113 💬 |
471 |
Other: metformin |
Metformin |
2件: D00944 D00944, D04966 D04966 💬 |
PRKAA1 2件: PRKAA1, PRKAA2 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
046 1件: 46 💬 |
472 |
Other: methacholine challenge test |
Methacholine |
- |
- |
- |
096 1件: 96 💬 |
473 |
Other: methotrexate therapy |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
474 |
Other: mibg label with i123 or i124 |
- |
- |
- |
- |
006 1件: 6 💬 |
475 |
Other: microindentation |
- |
- |
- |
- |
172 1件: 172 💬 |
476 |
Other: mitoxantrone - immunomodulator |
Mitoxantrone |
2件: D02166 D02166, D08224 D08224 💬 |
TOP2A 2件: TOP2A, TOP2B 💬 |
Platinum drug resistance 1件: Platinum drug resistance |
013 1件: 13 💬 |
477 |
Other: mixed meal test evaluation test arm |
- |
- |
- |
- |
299 1件: 299 💬 |
478 |
Other: mixed meal tolerance test |
- |
- |
- |
- |
299 1件: 299 💬 |
479 |
Other: mobile platform exercise |
- |
- |
- |
- |
006 1件: 6 💬 |
480 |
Other: mock injection |
- |
- |
- |
- |
090 1件: 90 💬 |
481 |
Other: modified atkins diet |
- |
- |
- |
- |
145 1件: 145 💬 |
482 |
Other: modified mixed meal tolerance test |
- |
- |
- |
- |
065 1件: 65 💬 |
483 |
Other: modified oral glucose tolerance test |
Dextrose, unspecified form |
- |
- |
- |
065 1件: 65 💬 |
484 |
Other: modified paleolithic diet |
- |
- |
- |
- |
013 1件: 13 💬 |
485 |
Other: monthly assessments of functional motor abilities by a trained therapist |
- |
- |
- |
- |
003 1件: 3 💬 |
486 |
Other: motor assessments before taking regular pd treatment |
- |
- |
- |
- |
006 1件: 6 💬 |
487 |
Other: motor assessments on regular pd treatment |
- |
- |
- |
- |
006 1件: 6 💬 |
488 |
Other: mp+ddci |
- |
- |
- |
- |
006 1件: 6 💬 |
489 |
Other: mp-equivalent |
- |
- |
- |
- |
006 1件: 6 💬 |
490 |
Other: mp-low |
- |
- |
- |
- |
006 1件: 6 💬 |
491 |
Other: mri |
- |
- |
- |
- |
006 3件: 6 , 127, 206 💬 |
492 |
Other: multidisciplinary intensive rehabilitation treatment |
- |
- |
- |
- |
006 1件: 6 💬 |
493 |
Other: muscle oxygenation |
- |
- |
- |
- |
299 1件: 299 💬 |
494 |
Other: music |
- |
- |
- |
- |
006 1件: 6 💬 |
495 |
Other: mybetaapp |
- |
- |
- |
- |
013 1件: 13 💬 |
496 |
Other: natalizumab |
Natalizumab |
1件: D06886 D06886 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
497 |
Other: natalizumab discontinuation |
Natalizumab |
1件: D06886 D06886 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
498 |
Other: natural herbs of coconut, aloe vera, and pepperint |
Aloe Vera Leaf |
- |
- |
- |
053 1件: 53 💬 |
499 |
Other: nbt-nm108 (0 g/day) |
- |
- |
- |
- |
013 1件: 13 💬 |
500 |
Other: neupro 4 mg / 24 hr. transdermal patch |
- |
- |
- |
- |
006 1件: 6 💬 |
501 |
Other: neurology exam |
- |
- |
- |
- |
019 1件: 19 💬 |
502 |
Other: neuromuscular evaluation |
- |
- |
- |
- |
013 1件: 13 💬 |
503 |
Other: nil per os |
- |
- |
- |
- |
291 1件: 291 💬 |
504 |
Other: nintendo wii fit balance exercises |
Isoxaflutole |
- |
- |
- |
013 1件: 13 💬 |
505 |
Other: no active treatment |
- |
- |
- |
- |
274 1件: 274 💬 |
506 |
Other: no anti-inflammatory treatment |
- |
- |
- |
- |
271 1件: 271 💬 |
507 |
Other: no device |
- |
- |
- |
- |
013 1件: 13 💬 |
508 |
Other: no doxycycline |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
299 1件: 299 💬 |
509 |
Other: no enzyme therapy |
- |
- |
- |
- |
298 1件: 298 💬 |
510 |
Other: no intervention |
- |
- |
- |
- |
070 1件: 70 💬 |
511 |
Other: no intervention: standard of care |
- |
- |
- |
- |
085 1件: 85 💬 |
512 |
Other: no it treatment |
- |
- |
- |
- |
019 1件: 19 💬 |
513 |
Other: no msdmds therapy (control) |
- |
- |
- |
- |
013 1件: 13 💬 |
514 |
Other: no pancreatic enzyme replacement therapy |
- |
- |
- |
- |
299 1件: 299 💬 |
515 |
Other: no plasma exchange |
- |
- |
- |
- |
043 2件: 43, 44 💬 |
516 |
Other: no treatment |
- |
- |
- |
- |
053 2件: 53, 256 💬 |
517 |
Other: no treatment arm |
- |
- |
- |
- |
013 1件: 13 💬 |
518 |
Other: no treatment given |
- |
- |
- |
- |
078 1件: 78 💬 |
519 |
Other: non impact aerobics |
- |
- |
- |
- |
013 1件: 13 💬 |
520 |
Other: non-hormonal period |
- |
- |
- |
- |
299 1件: 299 💬 |
521 |
Other: non-motor symptoms |
- |
- |
- |
- |
006 1件: 6 💬 |
522 |
Other: noninvasive actigraphy monitor |
Methamidophos |
- |
- |
- |
086 1件: 86 💬 |
523 |
Other: nordic walking (only osteoporosis group) |
- |
- |
- |
- |
006 1件: 6 💬 |
524 |
Other: normal (control) diet |
- |
- |
- |
- |
240 1件: 240 💬 |
525 |
Other: normal diet |
- |
- |
- |
- |
096 1件: 96 💬 |
526 |
Other: normal saline |
- |
- |
- |
- |
013 4件: 13, 222, 226, 280 💬 |
527 |
Other: normal saline for injection |
- |
- |
- |
- |
084 1件: 84 💬 |
528 |
Other: ns |
- |
- |
- |
- |
096 1件: 96 💬 |
529 |
Other: numerical rating scale |
- |
- |
- |
- |
046 1件: 46 💬 |
530 |
Other: nutrition counseling |
- |
- |
- |
- |
298 1件: 298 💬 |
531 |
Other: obese |
- |
- |
- |
- |
075 1件: 75 💬 |
532 |
Other: observation |
- |
- |
- |
- |
265 1件: 265 💬 |
533 |
Other: observation of ocrelizumab as treatment in rrms patients |
Ocrelizumab |
1件: D05218 D05218 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
534 |
Other: observation only |
- |
- |
- |
- |
331 1件: 331 💬 |
535 |
Other: observational |
- |
- |
- |
- |
090 1件: 90 💬 |
536 |
Other: observational cohort |
- |
- |
- |
- |
006 1件: 6 💬 |
537 |
Other: observational control |
- |
- |
- |
- |
013 1件: 13 💬 |
538 |
Other: ogtt |
- |
- |
- |
- |
299 1件: 299 💬 |
539 |
Other: on-demand treatment |
- |
- |
- |
- |
299 1件: 299 💬 |
540 |
Other: one-leg stance test |
- |
- |
- |
- |
013 1件: 13 💬 |
541 |
Other: ophthalmologic examinations |
- |
- |
- |
- |
299 1件: 299 💬 |
542 |
Other: optimized supportive care |
- |
- |
- |
- |
066 1件: 66 💬 |
543 |
Other: optimizing basal infusion (b.i) |
- |
- |
- |
- |
070 1件: 70 💬 |
544 |
Other: optional blood-oxygen-level dependent functionalmri |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
006 1件: 6 💬 |
545 |
Other: oral glucose tolerance test |
Dextrose, unspecified form |
- |
- |
- |
160 3件: 160, 195, 299 💬 |
546 |
Other: oral glucose tolerance test (ogtt) assessment arm |
Dextrose, unspecified form |
- |
- |
- |
299 1件: 299 💬 |
547 |
Other: oral nitric oxide testing |
Nitric Oxide |
1件: D00074 D00074 💬 |
- |
- |
098 1件: 98 💬 |
548 |
Other: other biologic agents |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
549 |
Other: other intervention(s) |
- |
- |
- |
- |
070 1件: 70 💬 |
550 |
Other: other: disease modifying therapies (dmt) |
- |
- |
- |
- |
013 1件: 13 💬 |
551 |
Other: other: symptomatic treatment of als |
- |
- |
- |
- |
002 1件: 2 💬 |
552 |
Other: outpatient rheumatology department |
- |
- |
- |
- |
046 1件: 46 💬 |
553 |
Other: overnight metyrapone test |
Metyrapone |
2件: D00410 D00410, D05019 D05019 💬 |
CYP11B1 1件: CYP11B1 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis |
193 1件: 193 💬 |
554 |
Other: oxygen |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
085 1件: 85 💬 |
555 |
Other: oxygen (2liter/min) |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
085 1件: 85 💬 |
556 |
Other: oxygen (4liter/min) |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
085 1件: 85 💬 |
557 |
Other: oxygen - air |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
299 1件: 299 💬 |
558 |
Other: oxygen supplementation |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
086 1件: 86 💬 |
559 |
Other: packing |
- |
- |
- |
- |
227 1件: 227 💬 |
560 |
Other: pain |
- |
- |
- |
- |
013 1件: 13 💬 |
561 |
Other: palliative care |
- |
- |
- |
- |
019 5件: 19, 65, 120, 160, 326 💬 |
562 |
Other: parkinson mpower mobile application |
- |
- |
- |
- |
006 1件: 6 💬 |
563 |
Other: passive : lecture series |
- |
- |
- |
- |
013 1件: 13 💬 |
564 |
Other: pcdai |
- |
- |
- |
- |
096 1件: 96 💬 |
565 |
Other: pd exercise intervention |
- |
- |
- |
- |
006 1件: 6 💬 |
566 |
Other: pd vitamin + exercise |
- |
- |
- |
- |
006 1件: 6 💬 |
567 |
Other: peak |
- |
- |
- |
- |
013 1件: 13 💬 |
568 |
Other: peanut butter |
Peanut |
- |
- |
- |
013 1件: 13 💬 |
569 |
Other: pentadecanoic acid (pa) and triheptadecanoin (tha) |
- |
- |
- |
- |
299 1件: 299 💬 |
570 |
Other: pentasa (mesalamine/ 5-aminosalicylic acid (5-asa) |
Aminosalicylic acid |
2件: D00162 D00162, D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
571 |
Other: periodized exercise training |
- |
- |
- |
- |
013 1件: 13 💬 |
572 |
Other: pharmacogenomic study |
- |
- |
- |
- |
026 1件: 26 💬 |
573 |
Other: pharmacokinetic analysis |
- |
- |
- |
- |
049 1件: 49 💬 |
574 |
Other: pharmacological study |
- |
- |
- |
- |
028 7件: 28, 34, 62, 74, 89, 232, 331 💬 |
575 |
Other: phenylalanine (phe)-restricted diet |
Phenylalanine |
1件: D00021 D00021 💬 |
- |
- |
240 1件: 240 💬 |
576 |
Other: physalis angulata ethanol extract |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
051 1件: 51 💬 |
577 |
Other: physical function performance test |
- |
- |
- |
- |
006 1件: 6 💬 |
578 |
Other: physical therapy |
- |
- |
- |
- |
006 2件: 6 , 70 💬 |
579 |
Other: pittsburgh compound b [11c]-pib |
Pittsburgh Compound B |
- |
- |
- |
006 1件: 6 💬 |
580 |
Other: plant-based diet |
- |
- |
- |
- |
046 1件: 46 💬 |
581 |
Other: plasticity-based computerized cognitive remediation program |
- |
- |
- |
- |
013 1件: 13 💬 |
582 |
Other: pnf |
- |
- |
- |
- |
013 1件: 13 💬 |
583 |
Other: position sense |
- |
- |
- |
- |
013 1件: 13 💬 |
584 |
Other: postoperative nausea and vomiting at 24 hour |
- |
- |
- |
- |
235 1件: 235 💬 |
585 |
Other: postoperative nausea and vomiting at 6 hour |
- |
- |
- |
- |
235 1件: 235 💬 |
586 |
Other: postoperative pain at 24 hour |
- |
- |
- |
- |
235 1件: 235 💬 |
587 |
Other: postoperative pain at 6 hour |
- |
- |
- |
- |
235 1件: 235 💬 |
588 |
Other: postoperative sore throat and hoarseness at 24 hour |
- |
- |
- |
- |
235 1件: 235 💬 |
589 |
Other: postoperative sore throat and hoarseness at 6 hour |
- |
- |
- |
- |
235 1件: 235 💬 |
590 |
Other: potable water |
Water |
1件: D00001 D00001 💬 |
- |
- |
019 1件: 19 💬 |
591 |
Other: prednisone |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
046 1件: 46 💬 |
592 |
Other: pretreatment antibiotics |
- |
- |
- |
- |
097 1件: 97 💬 |
593 |
Other: progressive exercise |
- |
- |
- |
- |
013 1件: 13 💬 |
594 |
Other: propensity score |
- |
- |
- |
- |
013 1件: 13 💬 |
595 |
Other: prospective observational registry |
- |
- |
- |
- |
003 1件: 3 💬 |
596 |
Other: psp |
- |
- |
- |
- |
013 1件: 13 💬 |
597 |
Other: pth based calcium carbonate and calcitriol repletion |
Calcitriol |
3件: D00129 D00129, D00932 D00932, D10802 D10802 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
235 1件: 235 💬 |
598 |
Other: pulmonary function testing (pft) |
- |
- |
- |
- |
113 1件: 113 💬 |
599 |
Other: pulmonary rehabilitation program |
- |
- |
- |
- |
085 1件: 85 💬 |
600 |
Other: qalcimum questionnaire |
- |
- |
- |
- |
013 2件: 13, 46 💬 |
601 |
Other: quality of life assessment |
- |
- |
- |
- |
122 1件: 122 💬 |
602 |
Other: quality of life questionnaire |
- |
- |
- |
- |
019 1件: 19 💬 |
603 |
Other: quality-of-life assessment |
- |
- |
- |
- |
034 5件: 34, 36, 51, 96, 298 💬 |
604 |
Other: quercetin |
Quercetin |
- |
- |
- |
299 1件: 299 💬 |
605 |
Other: questionnaire administration |
- |
- |
- |
- |
016 4件: 16, 34, 51, 298 💬 |
606 |
Other: questionnaires |
- |
- |
- |
- |
006 5件: 6 , 13, 41, 93, 96 💬 |
607 |
Other: reaction time and postural control |
- |
- |
- |
- |
299 1件: 299 💬 |
608 |
Other: real-time data capture app |
Bifenthrin |
- |
- |
- |
046 1件: 46 💬 |
609 |
Other: recommendation with regard to nutrition |
- |
- |
- |
- |
006 1件: 6 💬 |
610 |
Other: reduction group 1 |
- |
- |
- |
- |
046 1件: 46 💬 |
611 |
Other: reduction group 2 |
- |
- |
- |
- |
046 1件: 46 💬 |
612 |
Other: refered to general practice |
- |
- |
- |
- |
046 1件: 46 💬 |
613 |
Other: resistance exercise program |
- |
- |
- |
- |
046 1件: 46 💬 |
614 |
Other: review of past medical history, clinical exam, and electroencephalogram, polysomnography and urine samples of melatonin and pupillometry. |
Melatonin |
1件: D08170 D08170 💬 |
MTNR1A 2件: MTNR1A, MTNR1B 💬 |
Circadian entrainment 2件: Circadian entrainment, Neuroactive ligand-receptor interaction |
149 1件: 149 💬 |
615 |
Other: rhythmic auditory stimulation (ras) |
- |
- |
- |
- |
006 2件: 6 , 13 💬 |
616 |
Other: rhythmic balance-movement training (rbmt) |
Isoxaflutole |
- |
- |
- |
006 1件: 6 💬 |
617 |
Other: rmst |
- |
- |
- |
- |
256 1件: 256 💬 |
618 |
Other: rosemary essential oil |
Rosemary |
- |
- |
- |
051 1件: 51 💬 |
619 |
Other: rotigotine |
Rotigotine |
1件: D05768 D05768 💬 |
DRD2 1件: DRD2 💬 |
Alcoholism 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
620 |
Other: routine |
- |
- |
- |
- |
240 1件: 240 💬 |
621 |
Other: routine management |
- |
- |
- |
- |
291 1件: 291 💬 |
622 |
Other: routine therapy |
- |
- |
- |
- |
299 1件: 299 💬 |
623 |
Other: rp% measurement by fcm as a diagnostic test for itp |
- |
- |
- |
- |
063 1件: 63 💬 |
624 |
Other: salbutamol nebulisation and with cpap |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
228 1件: 228 💬 |
625 |
Other: saline |
- |
- |
- |
- |
002 8件: 2 , 6 , 46, 97, 98, 256, 274, 301 💬 |
626 |
Other: saline as a nasal spray |
- |
- |
- |
- |
226 1件: 226 💬 |
627 |
Other: saline solution |
- |
- |
- |
- |
067 1件: 67 💬 |
628 |
Other: saline solution. |
- |
- |
- |
- |
067 1件: 67 💬 |
629 |
Other: screening to prevent falls |
- |
- |
- |
- |
006 1件: 6 💬 |
630 |
Other: serum calcium concentrations results |
Calcium |
- |
- |
- |
235 1件: 235 💬 |
631 |
Other: serum levels of angiogenin, bfgf, vegf |
Basic Fibroblast Growth Factor |
- |
- |
- |
056 1件: 56 💬 |
632 |
Other: sham |
- |
- |
- |
- |
019 2件: 19, 301 💬 |
633 |
Other: sham (no implant) |
- |
- |
- |
- |
090 1件: 90 💬 |
634 |
Other: sham abdominal compression |
- |
- |
- |
- |
017 1件: 17 💬 |
635 |
Other: sham comparator |
- |
- |
- |
- |
299 1件: 299 💬 |
636 |
Other: sham group |
- |
- |
- |
- |
006 1件: 6 💬 |
637 |
Other: sham procedure |
- |
- |
- |
- |
090 1件: 90 💬 |
638 |
Other: sham surgery |
- |
- |
- |
- |
006 1件: 6 💬 |
639 |
Other: sham-procedure (dose cohort 1&2 only) |
- |
- |
- |
- |
090 2件: 90, 303 💬 |
640 |
Other: simvastatin |
Simvastatin |
1件: D00434 D00434 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
046 1件: 46 💬 |
641 |
Other: sle treatment |
- |
- |
- |
- |
049 1件: 49 💬 |
642 |
Other: smartphone application |
- |
- |
- |
- |
049 1件: 49 💬 |
643 |
Other: smartphone-based balance exercises |
Isoxaflutole |
- |
- |
- |
006 1件: 6 💬 |
644 |
Other: sodium chloride |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
051 1件: 51 💬 |
645 |
Other: specific sl-therapy |
- |
- |
- |
- |
006 1件: 6 💬 |
646 |
Other: specifically design 6 month resistance training program |
- |
- |
- |
- |
013 1件: 13 💬 |
647 |
Other: spinning grp |
- |
- |
- |
- |
013 1件: 13 💬 |
648 |
Other: sputum sample |
- |
- |
- |
- |
299 1件: 299 💬 |
649 |
Other: standard |
- |
- |
- |
- |
067 1件: 67 💬 |
650 |
Other: standard blood pressure control |
- |
- |
- |
- |
067 1件: 67 💬 |
651 |
Other: standard care |
- |
- |
- |
- |
227 1件: 227 💬 |
652 |
Other: standard immune suppression, oral |
- |
- |
- |
- |
228 1件: 228 💬 |
653 |
Other: standard nutrition |
- |
- |
- |
- |
096 1件: 96 💬 |
654 |
Other: standard of care |
- |
- |
- |
- |
013 7件: 13, 49, 64, 85, 96, 245, 246 💬 |
655 |
Other: standard of care (soc) |
- |
- |
- |
- |
062 1件: 62 💬 |
656 |
Other: standard of care sildenafil |
Sildenafil |
2件: D02229 D02229, D08514 D08514 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
090 2件: 90, 301 💬 |
657 |
Other: standard steroid treatment |
- |
- |
- |
- |
113 1件: 113 💬 |
658 |
Other: standard therapy |
- |
- |
- |
- |
049 1件: 49 💬 |
659 |
Other: standard treatment |
- |
- |
- |
- |
227 1件: 227 💬 |
660 |
Other: standard treatment according to the clinical protocols |
- |
- |
- |
- |
049 1件: 49 💬 |
661 |
Other: standard-of-care |
- |
- |
- |
- |
086 1件: 86 💬 |
662 |
Other: standardized meals |
- |
- |
- |
- |
086 1件: 86 💬 |
663 |
Other: standardized scales: mds-updrs (part ii to iv) and rdrs |
- |
- |
- |
- |
006 1件: 6 💬 |
664 |
Other: static balance test |
Isoxaflutole |
- |
- |
- |
013 1件: 13 💬 |
665 |
Other: stem cell transplant |
- |
- |
- |
- |
096 1件: 96 💬 |
666 |
Other: sterile normal saline (0.9% nacl) |
- |
- |
- |
- |
231 1件: 231 💬 |
667 |
Other: sterile saline |
- |
- |
- |
- |
046 1件: 46 💬 |
668 |
Other: stool sample |
- |
- |
- |
- |
006 2件: 6 , 299 💬 |
669 |
Other: strength training |
- |
- |
- |
- |
013 1件: 13 💬 |
670 |
Other: subacute hypoxic exposures |
- |
- |
- |
- |
086 1件: 86 💬 |
671 |
Other: subconjunctival injection of saline |
- |
- |
- |
- |
090 1件: 90 💬 |
672 |
Other: sugar pill |
- |
- |
- |
- |
090 1件: 90 💬 |
673 |
Other: sulfur pool & medicinal mud |
- |
- |
- |
- |
046 1件: 46 💬 |
674 |
Other: supervised physical therapy |
- |
- |
- |
- |
013 1件: 13 💬 |
675 |
Other: surgery |
- |
- |
- |
- |
074 2件: 74, 96 💬 |
676 |
Other: swallowing quality of life questionnaire |
- |
- |
- |
- |
002 1件: 2 💬 |
677 |
Other: swallowing related quality of life questionnaire |
- |
- |
- |
- |
002 1件: 2 💬 |
678 |
Other: symptom survey |
- |
- |
- |
- |
098 1件: 98 💬 |
679 |
Other: symptomatic hypocalcaemia at 24 hour |
- |
- |
- |
- |
235 1件: 235 💬 |
680 |
Other: symptomatic hypocalcaemia at 6 hour |
- |
- |
- |
- |
235 1件: 235 💬 |
681 |
Other: t-dcs group |
- |
- |
- |
- |
006 1件: 6 💬 |
682 |
Other: tampa kinesiophobia scale, berg-balance test, international physical activity questionnaire-short form, falls efficacy scale |
Isoxaflutole |
- |
- |
- |
006 1件: 6 💬 |
683 |
Other: technetium [tc-99m] sulfur colloid and indium [in-111] dtpa |
Indium |
1件: D05422 D05422 💬 |
- |
- |
299 1件: 299 💬 |
684 |
Other: test soda |
- |
- |
- |
- |
299 1件: 299 💬 |
685 |
Other: the center for neurologic studies bulbar function scale |
- |
- |
- |
- |
002 1件: 2 💬 |
686 |
Other: the center for neurologic study bulbar function scale |
- |
- |
- |
- |
002 1件: 2 💬 |
687 |
Other: the patients' parents have to complete the vineland ii adaptive behavior scales scoring, the sleep disturbance scale for children (sdsc) and horne & ostberg circadian typology questionnaire |
- |
- |
- |
- |
149 1件: 149 💬 |
688 |
Other: the timed 360° turn test |
- |
- |
- |
- |
006 1件: 6 💬 |
689 |
Other: therapy education |
- |
- |
- |
- |
097 1件: 97 💬 |
690 |
Other: threonine |
Threonine |
1件: D00041 D00041 💬 |
- |
- |
096 2件: 96, 97 💬 |
691 |
Other: timed up an go test |
- |
- |
- |
- |
013 1件: 13 💬 |
692 |
Other: timed up and go test |
- |
- |
- |
- |
006 1件: 6 💬 |
693 |
Other: tobacco questionnaire |
Tobacco leaf |
- |
- |
- |
299 1件: 299 💬 |
694 |
Other: tobramycin time of administration |
Tobramycin |
2件: D00063 D00063, D02542 D02542 💬 |
- |
- |
299 1件: 299 💬 |
695 |
Other: training groupe |
- |
- |
- |
- |
013 1件: 13 💬 |
696 |
Other: transthoracic echocardiography at rest, during plr, hg and cpx (including blood gas analysis in both groups). additionally fallot patients will undergo routine blood testings. |
- |
- |
- |
- |
215 1件: 215 💬 |
697 |
Other: triangular test |
- |
- |
- |
- |
096 1件: 96 💬 |
698 |
Other: trunk impairment |
- |
- |
- |
- |
013 1件: 13 💬 |
699 |
Other: trunk impairment scale |
- |
- |
- |
- |
006 1件: 6 💬 |
700 |
Other: trunk position sense |
- |
- |
- |
- |
013 1件: 13 💬 |
701 |
Other: tyramine |
Tyramine |
- |
- |
- |
006 1件: 6 💬 |
702 |
Other: uc-mscs by peripheral intravenous infusion |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
096 1件: 96 💬 |
703 |
Other: ulcerative colitis diet |
- |
- |
- |
- |
097 1件: 97 💬 |
704 |
Other: ultrasonography assessment |
- |
- |
- |
- |
049 1件: 49 💬 |
705 |
Other: unified parkinson's disease rating scale |
- |
- |
- |
- |
006 1件: 6 💬 |
706 |
Other: untreated cohort |
- |
- |
- |
- |
085 1件: 85 💬 |
707 |
Other: use of a postpartum diary and additional blood draws |
- |
- |
- |
- |
288 1件: 288 💬 |
708 |
Other: use of a postpartum diary and additional blood draws. |
- |
- |
- |
- |
288 1件: 288 💬 |
709 |
Other: uspio mri - gadolinium mri |
Gadolinium |
- |
- |
- |
013 1件: 13 💬 |
710 |
Other: usual care |
- |
- |
- |
- |
046 1件: 46 💬 |
711 |
Other: usual care arm exercise |
- |
- |
- |
- |
006 1件: 6 💬 |
712 |
Other: usual drug treatment of parkinson's disease |
- |
- |
- |
- |
006 1件: 6 💬 |
713 |
Other: vasculopathy assessment |
- |
- |
- |
- |
051 1件: 51 💬 |
714 |
Other: vegan diet |
- |
- |
- |
- |
046 1件: 46 💬 |
715 |
Other: vegetable oil |
- |
- |
- |
- |
257 1件: 257 💬 |
716 |
Other: vehicle |
- |
- |
- |
- |
160 1件: 160 💬 |
717 |
Other: vehicle (d5w or saline) |
- |
- |
- |
- |
066 1件: 66 💬 |
718 |
Other: vestibular habituation exercises |
- |
- |
- |
- |
013 1件: 13 💬 |
719 |
Other: vestibular rehabilitation: balance and eye movement exercises |
Isoxaflutole |
- |
- |
- |
013 1件: 13 💬 |
720 |
Other: virtual reality group |
- |
- |
- |
- |
013 1件: 13 💬 |
721 |
Other: visual acuity (va) |
- |
- |
- |
- |
090 2件: 90, 301 💬 |
722 |
Other: vital signs |
- |
- |
- |
- |
019 1件: 19 💬 |
723 |
Other: vitamin k |
Phylloquinone |
1件: D00148 D00148 💬 |
- |
- |
013 1件: 13 💬 |
724 |
Other: vitamin k cream |
Phylloquinone |
1件: D00148 D00148 💬 |
- |
- |
013 1件: 13 💬 |
725 |
Other: voluntary cough test |
- |
- |
- |
- |
006 1件: 6 💬 |
726 |
Other: walk distance test |
- |
- |
- |
- |
058 1件: 58 💬 |
727 |
Other: water |
Water |
1件: D00001 D00001 💬 |
- |
- |
067 1件: 67 💬 |
728 |
Other: water prescription |
Water |
1件: D00001 D00001 💬 |
- |
- |
067 1件: 67 💬 |
729 |
Other: wheat flour |
Wheat |
1件: D06902 D06902 💬 |
- |
- |
266 1件: 266 💬 |
730 |
Other: withdrawal from alpha1 antitrypsin replacement therapy |
- |
- |
- |
- |
231 1件: 231 💬 |
731 |
Other: withdrawal of dalfampridine-er 10mg |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
732 |
Other: xanthan gum |
Xanthan gum |
1件: D06333 D06333 💬 |
- |
- |
098 1件: 98 💬 |
733 |
Otilimab |
Otilimab |
1件: D11343 D11343 💬 |
CSF2 1件: CSF2 💬 |
Acute myeloid leukemia 16件: Acute myeloid leukemia, Amoebiasis, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, IL-17 signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Natural killer cell mediated cytotoxicity, Rheumatoid arthritis, Shigellosis, T cell receptor signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer |
046 1件: 46 💬 |
734 |
Otilimab (gsk3196165) |
Otilimab |
1件: D11343 D11343 💬 |
CSF2 1件: CSF2 💬 |
Acute myeloid leukemia 16件: Acute myeloid leukemia, Amoebiasis, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, IL-17 signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Natural killer cell mediated cytotoxicity, Rheumatoid arthritis, Shigellosis, T cell receptor signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer |
046 1件: 46 💬 |
735 |
Otl-101 |
- |
- |
- |
- |
065 1件: 65 💬 |
736 |
Otl-103 |
- |
- |
- |
- |
065 1件: 65 💬 |
737 |
Otl-103 dispersion for infusion |
- |
- |
- |
- |
065 1件: 65 💬 |
738 |
Otl-200 dispersion for infusion |
- |
- |
- |
- |
019 1件: 19 💬 |
739 |
Otl38 |
- |
- |
- |
- |
046 1件: 46 💬 |
740 |
Phase 1: methotrexate |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
741 |
Pn 200 tablets (500 mg naproxen and 20 mg omeprazole) |
Naproxen |
5件: D00118 D00118, D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A 4件: ATP4A, ATP4B, PTGS1, PTGS2 💬 |
Alzheimer disease 26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 2件: 46, 271 💬 |
742 |
Po ciprofloxacin |
Ciprofloxacin |
2件: D00186 D00186, D02216 D02216 💬 |
- |
- |
299 1件: 299 💬 |
743 |
Procedure: other intervention(s) |
- |
- |
- |
- |
070 1件: 70 💬 |
744 |
Response to anakinra associated with methotrexate |
Anakinra |
3件: D00142 D00142, D02115 D02115, D02934 D02934 💬 |
DHFR 4件: DHFR, DHFR2, IL1R1, IL1R2 💬 |
Amoebiasis 20件: Amoebiasis, Antifolate resistance, Biosynthesis of cofactors, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Folate biosynthesis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, Metabolic pathways, NF-kappa B signaling pathway, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer |
046 1件: 46 💬 |
745 |
Response to infliximab associated with methotrexate |
Infliximab |
3件: D00142 D00142, D02115 D02115, D02598 D02598 💬 |
DHFR 3件: DHFR, DHFR2, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 69件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 1件: 46 💬 |
746 |
Rifaximin+omeprazole+miralax |
Omeprazole |
5件: D00455 D00455, D01207 D01207, D02554 D02554, D05259 D05259, D05261 D05261 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
096 1件: 96 💬 |
747 |
See d.3.9.3 'other descriptive name' below |
- |
- |
- |
- |
046 1件: 46 💬 |
748 |
Stable weekly dose of methotrexate |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
749 |
Tacrolimus with methotrexate |
Methotrexate |
4件: D00107 D00107, D00142 D00142, D02115 D02115, D08556 D08556 💬 |
DHFR 7件: DHFR, DHFR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 37件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
046 1件: 46 💬 |
750 |
Tak-715 and methotrexate |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
751 |
Tak-783 and methotrexate |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
752 |
Tasocitinib plus methotrexate |
Methotrexate |
3件: D00142 D00142, D02115 D02115, D09970 D09970 💬 |
DHFR 6件: DHFR, DHFR2, JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 40件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Antifolate resistance, Biosynthesis of cofactors, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Folate biosynthesis, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, Metabolic pathways, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, One carbon pool by folate, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 1件: 46 💬 |
753 |
Tnf-alpha antagonist and other biotherapy |
- |
- |
- |
- |
046 1件: 46 💬 |
754 |
Tocilizumab + methotrexate(mtx) |
Methotrexate |
3件: D00142 D00142, D02115 D02115, D02596 D02596 💬 |
DHFR 3件: DHFR, DHFR2, IL6R 💬 |
Antifolate resistance 17件: Antifolate resistance, Biosynthesis of cofactors, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Folate biosynthesis, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Metabolic pathways, Non-alcoholic fatty liver disease, One carbon pool by folate, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 1件: 46 💬 |
755 |
Tocilizumab plus methotrexate |
Methotrexate |
3件: D00142 D00142, D02115 D02115, D02596 D02596 💬 |
DHFR 3件: DHFR, DHFR2, IL6R 💬 |
Antifolate resistance 17件: Antifolate resistance, Biosynthesis of cofactors, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Folate biosynthesis, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Metabolic pathways, Non-alcoholic fatty liver disease, One carbon pool by folate, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 1件: 46 💬 |
756 |
Tocilizumab+methotrexate(mtx) |
Methotrexate |
3件: D00142 D00142, D02115 D02115, D02596 D02596 💬 |
DHFR 3件: DHFR, DHFR2, IL6R 💬 |
Antifolate resistance 17件: Antifolate resistance, Biosynthesis of cofactors, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Folate biosynthesis, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Metabolic pathways, Non-alcoholic fatty liver disease, One carbon pool by folate, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 1件: 46 💬 |
757 |
Tofacitinib with methotrexate |
Methotrexate |
3件: D00142 D00142, D02115 D02115, D09970 D09970 💬 |
DHFR 6件: DHFR, DHFR2, JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 40件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Antifolate resistance, Biosynthesis of cofactors, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Folate biosynthesis, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, Metabolic pathways, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, One carbon pool by folate, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 1件: 46 💬 |
758 |
Tofacitinib without methotrexate |
Methotrexate |
3件: D00142 D00142, D02115 D02115, D09970 D09970 💬 |
DHFR 6件: DHFR, DHFR2, JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 40件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Antifolate resistance, Biosynthesis of cofactors, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Folate biosynthesis, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, Metabolic pathways, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, One carbon pool by folate, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 1件: 46 💬 |
759 |
Treatment with systemic therapy (methotrexate) |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
162 1件: 162 💬 |
760 |
Urine samples taken to measure methotrexate and its major metabolite 7-oh-methotrexate level |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |